According to a survey conducted by research company Active Group and the Experts Club analytical center in early February, 28.4% of Ukrainians prefer Ukrainian medicines.
According to Alexander Pozniy, CEO and co-founder of Active Group, 33.4% of respondents more often choose imported medicines, while for 38.2% of respondents, the country of origin of the drug is irrelevant.
“For manufacturers, this means that competition is based on reputation, proven effectiveness, and stability of supply, and Ukrainian brands can strengthen their position through quality and clear communication,” said Alexander Pozniy, CEO and co-founder of Active Group.
According to Experts Club founder Maxim Urakin, “the fact that almost a third of consumers choose domestic drugs shows the importance of accessibility and trust in quality in the domestic market.”
The study was conducted on the SunFlowerSociology online panel on a representative sample on February 11-12, 2026. The survey involved 1,000 respondents from a representative sample in all regions of Ukraine, except for the temporarily occupied territories.
ACTIVE GROUP, EXPERTS CLUB, Pozniy, SOCIOLOGY, SOLONINKA, SURVEY, URAKIN
